In highly regulated pharmaceutical operations, companies invest significant time and resources into physical security, inventory controls, DEA registrations, and state licensing requirements. Yet one of the most important safeguards protecting controlled substances often receives far less attention than it deserves: employee screening.
For organizations that manufacture, distribute, import, export, reverse distribute, or otherwise handle controlled substances, employee screening is not simply an HR function. It is a regulatory expectation that plays a critical role in preventing diversion and protecting the integrity of the pharmaceutical supply chain.
The challenge is that these requirements can easily fade into the background. They are rarely discussed during routine compliance meetings, and many organizations only revisit them during an inspection, internal audit, or after a staffing change. By then it may already be too late to correct documentation gaps or inconsistent hiring practices.
Access Is the Standard, Not Physical Handling
One of the most common misconceptions surrounding DEA employee screening is that the requirements only apply to employees who physically handle controlled substances.
That is not the standard established by the DEA.
Under 21 CFR § 1301.90, the determining factor is whether an employee has access to controlled substances or works in an area where access clearly exists. This distinction significantly broadens the scope of employees who should be evaluated before assuming their responsibilities.
Depending on an organization’s operations, employees working in receiving, warehousing, inventory management, quality assurance, security, shipping, returns, destruction, or other operational functions may all fall within this category. Even individuals whose responsibilities are administrative or supervisory may require screening if their position provides operational access to controlled substances.
Understanding who has access is often the first step toward identifying compliance gaps.
Employee Screening Is Part of DEA Security Expectations
The DEA considers employee screening to be a fundamental component of an organization’s overall security program.
Before employees are granted access to controlled substances, companies should obtain sufficient information to fairly evaluate the likelihood that an individual could contribute to a drug security breach. This includes reviewing criminal history, determining whether there are pending criminal charges, evaluating certain recent drug use, obtaining written authorization to conduct appropriate inquiries, and ensuring applicants understand that false statements or omissions may affect employment decisions.
The process should also include evaluating whether an individual has a history that could legally prohibit access to controlled substances, including certain controlled substance related felony convictions, previous DEA registration denials, revoked registrations, or registrations surrendered for cause. In some circumstances, a DEA employment waiver may be necessary before access can be granted.
These requirements are not intended to create unnecessary administrative work. They exist because personnel decisions are an essential layer of diversion prevention.
Compliance Does Not End After Hiring
Many organizations devote considerable attention to pre-employment screening but overlook the importance of maintaining consistent procedures after an employee joins the company.
Roles evolve, employees transfer between departments, responsibilities expand and an individual who initially had no controlled substance access may later move into a position that requires additional screening or documentation.
A well-designed compliance program accounts for these operational realities by maintaining clear standard operating procedures, documenting which positions require controlled substance access, retaining screening records, and ensuring cross-functional communication between Human Resources, Quality, Operations, and Regulatory Compliance before access is approved.
Periodic reviews can also help organizations identify outdated procedures before they become regulatory findings.
New Jersey Adds Another Layer of Responsibility
Companies operating in New Jersey should be especially mindful of additional state requirements.
The New Jersey Division of Consumer Affairs Drug Control Unit requires criminal background checks for individuals with physical access to controlled substances. Upon hiring employees into qualifying positions, organizations must complete the required Criminal History Record Information process and submit specific employee information to the Drug Control Unit.
While many organizations are familiar with federal DEA requirements, this state-specific notification requirement is sometimes overlooked, particularly by companies expanding operations into New Jersey or onboarding new compliance personnel.
It serves as an important reminder that controlled substance compliance rarely stops at the federal level. State requirements frequently introduce additional obligations that must be incorporated into internal procedures. For many organizations, that means reviewing and updating existing standard operating procedures to ensure they accurately reflect New Jersey’s Drug Control Unit notification requirements and clearly define the responsibilities of each department involved in the hiring process.
Just as importantly, companies should consider retraining Human Resources personnel and other employees responsible for onboarding to ensure they understand when additional screening, documentation, and state notifications are required. Even well-written SOPs are only effective if the teams responsible for executing them understand the process and apply it consistently.
Compliance Is Strongest When Departments Work Together
Effective employee screening is not solely the responsibility of Human Resources. It is a cross-functional process that depends on collaboration between HR, Operations, Quality, Security, and Regulatory Compliance to ensure every employee with controlled substance access is properly vetted before that access is granted.
Human Resources may oversee hiring and background screening, while Operations identifies which positions require access. Quality helps ensure established procedures are followed consistently, and Regulatory Compliance monitors changing federal and state requirements while maintaining documentation that can withstand regulatory scrutiny.
When these departments operate in silos, gaps can develop that increase compliance risk. A breakdown in communication can result in employees receiving access before screening is complete, documentation being overlooked, or evolving regulatory requirements going unnoticed. Organizations that foster collaboration across these functions are better equipped to maintain a secure, compliant operation and respond confidently during inspections or audits.
As regulatory expectations continue to evolve, companies that routinely evaluate their employee screening processes and encourage cross-departmental accountability are better positioned to reduce diversion risk, avoid costly inspection findings, and strengthen their overall compliance program.
Stay Ahead of Regulatory Risk
Employee screening is just one piece of a much larger compliance picture. As federal regulations evolve and states continue to introduce new requirements, maintaining a compliant pharmaceutical operation requires constant oversight, accurate documentation, and a proactive strategy.
Whether you’re managing a single facility or a nationwide portfolio of state licenses and DEA registrations, State License Servicing (SLS) helps pharmaceutical companies simplify compliance while reducing regulatory risk. Our team monitors changing requirements, manages licensing obligations across all 50 states and provides the Human Intelligence needed to help organizations navigate even the most complex regulatory challenges with confidence.
If you’re looking for a trusted compliance partner to strengthen your licensing program, improve operational efficiencies, or ensure your organization is prepared for its next inspection, contact our team today. We’ll help you turn regulatory complexity into a clear, manageable compliance strategy.